| CYSB2200226 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2022-09-15 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CXSL2400082 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-02-01 | | | | | view |
| CXSL2200317 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2022-07-14 | | Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd | | | view |
| CXSL2101500 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2021-12-22 | | Zhuhai GENE-BIOCON Biological Technology Co Ltd | | | view |
| CXSL2300092 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2023-02-08 | | Federal Biotechnology (Zhuhai Hengqin) Co Ltd | | | view |
| JYSZ2200009 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | License Renew | 2022-03-04 | | | | | view |
| CXSL2400436 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-07-09 | | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
| CYSB2101172 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2021-08-31 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CXSL2200241 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2022-06-03 | | | | | view |
| JYSB2400021 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products | Supplementary Application | 2024-02-01 | | | | | view |
| JYSB2101153 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2021-10-22 | | Novo Nordisk A/S | | | view |
| CXSL2400772 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-11-13 | | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
| CXSL2200458 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2022-09-14 | | Wanbang Biopharmaceuticals | | | view |
| CYSB2300007 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products | Supplementary Application | 2023-01-11 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| JTS2100532 | 德谷胰岛素二级标准品 | insulin degludec | Other | Biological Products | Disposable Import Drug Application | 2021-10-14 | | | | | view |
| CXSL2400293 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2024-05-09 | | Shandong New Time Pharmaceutical Co Ltd | | | view |
| JYSZ2200008 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | License Renew | 2022-03-04 | | | | | view |
| CYSB2200227 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2022-09-15 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CXSS2400110 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2024-10-12 | | Zhuhai Federal Biomedical Co Ltd | | | view |
| JYSB2200187 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2022-09-29 | | Novo Nordisk A/S | | | view |
